Indications for the sclerosing agent polidocanol.
Duffy
D M
DM
D006801:Humans; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*
D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols